Literature DB >> 3137914

Experimental hantavirus infection in nonhuman primates.

R Yanagihara1, H L Amyx, P W Lee, D M Asher, C J Gibbs, D C Gajdusek.   

Abstract

Mild, transient proteinuria and azotemia were produced in three cynomolgus monkeys (Macaca fascicularis) and a chimpanzee (Pan troglodytes) following intravenous inoculation with Prospect Hill virus, a hantavirus isolated from meadow voles in the United States. This is the first demonstration of an acute nephropathy in nonhuman primates with the viruses causing hemorrhagic fever with renal syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137914     DOI: 10.1007/bf01314657

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever.

Authors:  P A Webb; K M Johnson; R B Mackenzie; M L Kuns
Journal:  Am J Trop Med Hyg       Date:  1967-07       Impact factor: 2.345

2.  Partial characterization of Prospect Hill virus isolated from meadow voles in the United States.

Authors:  P W Lee; H L Amyx; R Yanagihara; D C Gajdusek; D Goldgaber; C J Gibbs
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome.

Authors:  C S Schmaljohn; S E Hasty; J M Dalrymple; J W LeDuc; H W Lee; C H von Bonsdorff; M Brummer-Korvenkontio; A Vaheri; T F Tsai; H L Regnery
Journal:  Science       Date:  1985-03-01       Impact factor: 47.728

4.  Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; H L Amyx; D C Gajdusek
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Prospect Hill virus: serologic evidence for infection in mammologists.

Authors:  R Yanagihara; D C Gajdusek; C J Gibbs; R Traub
Journal:  N Engl J Med       Date:  1984-05-17       Impact factor: 91.245

6.  A rhesus monkey model for the study of Bolivian hemorrhagic fever.

Authors:  M D Kastello; G A Eddy; R W Kuehne
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

7.  Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests.

Authors:  P W Lee; C J Gibbs; D C Gajdusek; R Yanagihara
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus).

Authors:  R Yanagihara; H L Amyx; D C Gajdusek
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

9.  Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.

Authors:  D H Walker; K M Johnson; J V Lange; J J Gardner; M P Kiley; J B McCormick
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

10.  Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

View more
  13 in total

1.  Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins.

Authors:  I N Gavrilovskaya; E J Brown; M H Ginsberg; E R Mackow
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 2.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

Review 3.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

4.  Extensive host sharing of central European Tula virus.

Authors:  Jonas Schmidt-Chanasit; Sandra Essbauer; Rasa Petraityte; Kumiko Yoshimatsu; Kirsten Tackmann; Franz J Conraths; Kestutis Sasnauskas; Jiro Arikawa; Astrid Thomas; Martin Pfeffer; Jerrold J Scharninghausen; Wolf Splettstoesser; Matthias Wenk; Gerald Heckel; Rainer G Ulrich
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.

Authors:  J Klingström; A Plyusnin; A Vaheri; A Lundkvist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

7.  Lethal disease in infant and juvenile Syrian hamsters experimentally infected with Imjin virus, a newfound crocidurine shrew-borne hantavirus.

Authors:  Se Hun Gu; Young-Sik Kim; Luck Ju Baek; Takeshi Kurata; Richard Yanagihara; Jin-Won Song
Journal:  Infect Genet Evol       Date:  2015-09-12       Impact factor: 3.342

8.  Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence.

Authors:  H Ebihara; K Yoshimatsu; M Ogino; K Araki; Y Ami; H Kariwa; I Takashima; D Li; J Arikawa
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

10.  Pathology of Puumala hantavirus infection in macaques.

Authors:  Tarja Sironen; Jonas Klingström; Antti Vaheri; Leif C Andersson; Ake Lundkvist; Alexander Plyusnin
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.